Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Neurological Sciences
Published in: Neurological Sciences 4/2019

01-04-2019 | Stroke | Original Article

Dementia: new vistas and opportunities

Author: Vladimir Hachinski

Published in: Neurological Sciences | Issue 4/2019

Login to get access

Abstract

Over the past four decades, Alzheimer disease has become near synonymous with dementia and the amyloid/tau hypothesis as its dominant explanation. However, this monorail approach to etiology has failed to yield a single disease-modifying drug. Part of the explanation stems from the fact that most dementias in the elderly result from interactive Alzheimer and cerebrovascular pathologies. Stroke and dementia share the same risk factors and their control is associated with a decrease in stroke and some dementias. Additionally, intensive control of risk factors and enhancement of protective factors improve cognition. Moreover, anticoagulation of atrial fibrillation patients decreases their chance of developing dementia by 48%. Preliminary data suggest that treating blood pressure to a target of 120 mmHg systolic compared to a target of 140 mmHg decreases the chances of mild cognitive impairment by 19%. The Berlin Manifesto establishes the scientific bases of “preventing dementia by preventing stroke.” Enlarging our vista of dementia to include cerebrovascular disease offers the opportunity of preventing not only stroke, but some dementias, beginning now.
Literature
1.
The Global Burden of Disease Study 2017 (2018) Lancet 392:10159
2.
3.
Jin YP, Di Legge S, Ostbye T, Feightner JW, Hachinski V (2006) The reciprocal risks of stroke and cognitive impairment in an elderly population. Alzheimers Dement 6:171–178CrossRef
4.
Kuzma E, Lourida I, Moore SF, Levine DA, Ukoumunne OC, Llewellyn DJ (2018) Stroke and dementia risk: a systematic and meta-analysis. Alzheimers Dement 14:1416–1428CrossRefPubMedPubMedCentral
5.
Solomon A, Mangialasche F, Richard E, Andrieu S, Bennett DA, Breteler MM, Fratiglioni L, Hooshmand B, Khachaturian AS, Schneider LS, Skoog I, Kivipelto M (2014) Advances in the prevention of Alzheimer’s disease and dementia. J Intern Med 275:229–250CrossRefPubMedPubMedCentral
6.
Rodrigue KM, Rieck JR, Kennedy KM, Devous MD Sr, Diaz-Arrastia R, Park DC (2013) Risk factors for β-amyloid deposition in healthy aging vascular and genetic effects. JAMA Neurol 70:600–606CrossRefPubMedPubMedCentral
7.
Nation DA, Edland SD, Bondi MW, Salmon DP, Delano-Wood L, Peskind ER, Quinn JF, Galasko DR (2013) Pulse pressure is associated with Alzheimer biomarkers in cognitively normal older adults. Neurol 81:2024–2027CrossRef
8.
Hughes TM, Kuller LH, Barinas-Mitchell EJM, McDade EM, Klunk WE, Cohen AD, Mathis CA, DeKosky ST, Price JC, Lopez OL (2014) Arterial stiffness and β-amyloid progression in nondemented elderly adults. JAMA Neurol 71:562–568CrossRefPubMedPubMedCentral
9.
Hooshmand B, Polvikoski T, Kivipelto M, Tanskanen M, Myllykangas L, Erkinjunttin T, Mäkelä M, Oinas M et al (2013) Alzheimer and cerebrovascular pathology: a population-based autopsy study. Brain 136:2707–271610CrossRefPubMedPubMedCentral
10.
Feigin VL (2016) Global burden of stroke and risk factors in 188 countries, during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet Neurol 15:913–924CrossRefPubMed
11.
O’Donnell MJ, Xavier D, Liu L et al (2010) Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 376:112–123CrossRefPubMed
12.
Chen H, Kwong JC, Copes R, Tu K, Villeneuve PJ, van Donkelaar A, Hystad P, Martin RV, Murray BJ, Jessiman B, Wilton AS, Kopp A, Burnett RT (2017) Living near major roads and the incidence of dementia, Parkinson’s disease, and multiple sclerosis: a population-based cohort study. Lancet 389:718–726CrossRefPubMed
13.
Livingston G, Sommerlad A. Orgeta V. Costafreda SG, Huntley J, Ames D, Ballard C et al (2017) Dementia prevention, intervention and care. The Lancet Commissions. Lancet
14.
Barnes DE, Byers AL, Gardner RC, Seal KH, Boscardin WJ, Yaffe K (2018) Association of mild traumatic brain injury with and without loss of consciousness with dementia in US military veterans. JAMA Neurol 75:1055–1061CrossRefPubMedPubMedCentral
15.
Azarpazhooh MR, Avan A, Cipriano LE, Munoz DG, Sposato LA, Hachinski V (2018) Concomitant vascular and neurodegenerative pathologies double the risk of dementia. Alzheimers Dement 14:148–156CrossRefPubMed
16.
Vermeer SE, Prins ND, Heijer TD, Hofman A, Koudstaal PJ, Breteler MMB (2003) Silent brain infarcts and the risk of dementia and cognitive decline. NEJM 348:1215–1222CrossRefPubMed
17.
18.
Hachinski V (2019) Dementia: a radical rethink. Alzheimers Dement in press
19.
Moroney JT, Bagiella E, Desmond DW, Hachinski VC, Mölsä PK, Gustafson L, Brun A, Fischer P, Erkinjuntti T, Rosen W, Paik MC, Tatemichi TK (1997) Meta-analysis of the Hachinski ischemic score in pathologically verified dementias. Neurology 49:1096–1105CrossRefPubMed
20.
Hachinski V, Oveisgharan S, Romney AK, Shankle WR (2012) Optimizing the Hachinski ischemic scale. Arch Neurol 69:169–175CrossRefPubMed
21.
Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, Lindley RI, O'Brien JT, Barkhof F, Benavente OR, Black SE, Brayne C, Breteler M, Chabriat H, Decarli C, de Leeuw FE, Doubal F, Duering M, Fox NC, Greenberg S, Hachinski V, Kilimann I, Mok V, Oostenbrugge Rv, Pantoni L, Speck O, Stephan BC, Teipel S, Viswanathan A, Werring D, Chen C, Smith C, van Buchem M, Norrving B, Gorelick PB, Dichgans M, STandards for ReportIng Vascular changes on nEuroimaging (STRIVE v1) (2013) Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. STandards for ReportIng Vascular changes on nEuroimaging (STRIVE v1). Lancet Neurol 12:822–838CrossRefPubMedPubMedCentral
22.
Thiel A, Cechetto DF, Heiss W-D, Hachinski V, Whitehead SN (2014) Amyloid burden, neuroinflammation, and links to cognitive decline after ischemic stroke. Stroke 45:2825–2829CrossRefPubMed
23.
Hachinski V, Iadecola C, Petersen RC, Breteler MM, Nyenhuis DL, Black SE, Powers WJ, DeCarli D et al (2006) National Institute of Neurological Disorders and Stroke–Canadian stroke network vascular cognitive impairment harmonization standards. Stroke 37:2220–2241CrossRefPubMed
24.
Samieri C, Perier M-C, Gaye B, Proust-Lima C, Helmer C, Dartigues J-F, Berr C, Tzourio C, Empana J-P (2018) Association of cardiovascular health level in older age with cognitive decline and incident dementia. JAMA 320:657–664CrossRefPubMedPubMedCentral
25.
Kapral MK, Fang J, Silver FL, Hall R, Stamplecoski M, O’Callaghan CTJV (2013) Effect of a provincial system of stroke care delivery on stroke care and outcomes. CMAJ 185:E483–E491lCrossRefPubMedPubMedCentral
26.
Webster F, Saposnik G, Kapral M, Fung J, O'Callaghan C, Hachinski V (2011) Organized outpatient care: Stroke prevention clinical referrals are associated with reduced mortality after transient ischemic attack and ischemic stroke. Stroke 42:3176–3182CrossRefPubMed
27.
Savva GM, Stephan BCM, the Alzheimer’s Society Vascular Dementia Systematic Review Group (2010) Epidemiological studies of the effect of stroke on incident dementia. A Systematic Review. Stroke 41:e41–e46
28.
Sposato LA, Kapral MK, Wu J, Gill SS, Hackam DG, Cipriano LE, Hachinski V (2015) Declining incidence of stroke and dementia: coincidence or prevention opportunity? JAMA Neurol 72:1529–1531CrossRefPubMed
29.
Ngandu T, Lehtisalo J, Solomon A, Levälahti E, Ahtiluoto S, Antikainen R, Bäckman L, Hänninen T, Jula A, Laatikainen T, Lindström J, Mangialasche F, Paajanen T, Pajala S, Peltonen M, Rauramaa R, Stigsdotter-Neely A, Strandberg T, Tuomilehto J, Soininen H, Kivipelto M (2015) A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet 385:2255–2263CrossRef
30.
Friberg L, Rosenqvist M (2018) Less dementia with oral anticoagulation in atrial fibrillation. Eur Heart J 39:453–460CrossRefPubMed
31.
Koizumi K, Hattori Y, Ahn SJ, Buendia I, Ciacciarelli A, Uekawa K, Wang G, Hiller A, Zhao L, Voss HU, Paul SM, Schaffer C, Park L, Iadecola C (2018) Apoε4 disrupts neurovascular regulation and undermines white matter integrity and cognitive function. Nat Commun 9:3816CrossRefPubMedPubMedCentral
32.
Hachinski V, World Stroke Organization (2015) Proclamation updated world stroke day proclamation. Stroke and potentially preventable dementias. Stroke 46:3039–3040CrossRefPubMed
33.
Hachinski V, Ganten D, Lackland D, Kreutz R, Tsioufis K, Hacke W, on behalf of the World Stroke Organization, the World Heart Federation, the World Hypertension League and the European Society of Hypertension (2018) Implementing the proclamation of stroke and potentially preventable dementias. Int J Stroke 13:780–786CrossRefPubMed
34.
Hachinski V (2018) Treatable and potentially preventable dementias. Cambridge University Press, United KingdomCrossRef
Metadata
Title
Dementia: new vistas and opportunities
Author
Vladimir Hachinski
Publication date
01-04-2019
Publisher
Springer International Publishing
Published in
Neurological Sciences / Issue 4/2019
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-019-3714-1

Other articles of this Issue 4/2019

Neurological Sciences 4/2019 Go to the issue

Brief Communication

Peroneal nerve mononeuropathy associated with herpes zoster. A case report

Brief Communication

Crossed obsessive-compulsive personality disorder and impaired theory of mind in temporal lobe epilepsy

Letter to the Editor

An unusual presentation of superficial siderosis with focal dystonia and ‘Giant panda morphology’ on MRI: atypical clinicoradiological amalgam

Original Article

Efficacy and safety of prothrombin complex concentrate for vitamin K antagonist-associated intracranial hemorrhage: a systematic review and meta-analysis

Original Article

Normative values of the Rao’s Brief Repeatable Battery in an Italian young adolescent population: the influence of age, gender, and education

Original Article

Migraine and subclinical atherosclerosis: endothelial dysfunction biomarkers and carotid intima-media thickness: a case-control study